• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    ArQule Inc. (ARQL)

    -NasdaqGM
    1.62 Up 0.06(3.85%) 4:00PM EDT
    Add to Portfolio
    Prev Close:1.56
    Open:1.57
    Bid:1.54 x 10000
    Ask:2.16 x 1300
    1y Target Est:4.50
    Beta:2.31
    Earnings Date:Aug 3 - Aug 7 (Est.)
    Day's Range:1.54 - 1.62
    52wk Range:1.04 - 2.50
    Volume:190,114
    Avg Vol (3m):297,049
    Market Cap:101.77M
    P/E (ttm):N/A
    EPS (ttm):-0.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARQLUp 3.85%101.77M
    ARRYDown 1.85%977.50M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.62
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.31
    Quarterly EPS Est (Jun-15) :-0.08
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):-1.15

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ArQule, Inc., a clinical-stage biotechnology company, researches and develops therapeutics for the treatment of cancer and rare diseases. Its lead product candidate is tivantinib, a small molecule inhibitor of the c-Met receptor tyrosine kinase an... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback